![High-dose daily treatments of caspofungin reduce GI burdens but also... | Download Scientific Diagram High-dose daily treatments of caspofungin reduce GI burdens but also... | Download Scientific Diagram](https://www.researchgate.net/publication/320186185/figure/fig1/AS:568012659806209@1512436179970/High-dose-daily-treatments-of-caspofungin-reduce-GI-burdens-but-also-lead-to-resistance_Q320.jpg)
High-dose daily treatments of caspofungin reduce GI burdens but also... | Download Scientific Diagram
![PDF] A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis. | Semantic Scholar PDF] A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/01b78806cea1e8eb1f407b16282304df02aefaed/4-Table2-1.png)
PDF] A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis. | Semantic Scholar
![Frontiers | Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation Frontiers | Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation](https://www.frontiersin.org/files/MyHome%20Article%20Library/510112/510112_Thumb_400.jpg)
Frontiers | Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation
![Ibrexafungerp Demonstrates In Vitro Activity against Fluconazole-Resistant Candida auris and In Vivo Efficacy with Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis | Antimicrobial Agents and Chemotherapy Ibrexafungerp Demonstrates In Vitro Activity against Fluconazole-Resistant Candida auris and In Vivo Efficacy with Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.02694-20/asset/9334c55d-3c14-494a-8825-9afdc9628873/assets/images/large/aac.02694-20-f001.jpg)